10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10

10% OFF

ON THE TOTAL FEE

Input this Professional Credit at checkout for a max $30.00 offset.

FAST10
** Fraud Prevention Notice      Be cautious of scams involving cloned emails and fake phone numbers requesting conference or journal fees. Only make payments via Science Net's official event platform and notify us immediately at [email protected] if you suspect fraud.

Hybrid Event

29th - 30th September 2026 | Zurich, Switzerland

International Conference on Pharmacy and Drug Regulation (ICPPDR - 26)

4

Days

4

Hrs

07

Min

02

Sec

Conference Program

Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

Why it matters

SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
SDG 16 — Peace, Justice and Strong Institutions
SDG 17 — Partnerships for the Goals
Explore All Session Tracks
Track 01
Advancements in Pharmaceutical Law

This track will explore recent developments in pharmaceutical law, focusing on the implications for drug regulation and compliance. Participants will discuss how evolving legal frameworks impact the pharmaceutical industry and public health.

Track 02
Regulatory Affairs in Global Context

This session will examine the role of regulatory affairs in the global pharmaceutical landscape. Emphasis will be placed on the challenges and best practices for navigating diverse regulatory environments.

Track 03
Pharmacy Policy and Public Health

This track will analyze the intersection of pharmacy policy and public health initiatives. Discussions will focus on how effective policy can enhance drug accessibility and safety.

Track 04
Drug Safety and Risk Management

This session will delve into strategies for ensuring drug safety throughout the product lifecycle. Participants will review case studies and regulatory frameworks that enhance risk management practices.

Track 05
Pharmaceutical Standards and Quality Assurance

This track will focus on the establishment and enforcement of pharmaceutical standards. Discussions will highlight the importance of quality assurance in maintaining drug efficacy and safety.

Track 06
Innovations in Clinical Pharmacy Practice

This session will showcase innovative practices in clinical pharmacy that improve patient outcomes. Participants will share insights on integrating new therapeutic approaches into pharmacy practice.

Track 07
Therapeutic Innovation and Drug Development

This track will explore the latest trends in therapeutic innovation and its impact on drug development. Discussions will include the role of research and collaboration in advancing new therapies.

Track 08
Compliance and Regulatory Challenges

This session will address the compliance challenges faced by pharmaceutical companies in meeting regulatory requirements. Participants will discuss strategies for effective compliance management.

Track 09
Pharmaceutical Research Methodologies

This track will highlight various research methodologies employed in pharmaceutical studies. Participants will examine the strengths and limitations of different approaches in advancing pharmaceutical knowledge.

Track 10
Ethics in Pharmacy and Drug Regulation

This session will explore ethical considerations in pharmacy practice and drug regulation. Discussions will focus on the responsibilities of pharmacists in promoting ethical standards.

Track 11
Future Directions in Pharmacy and Drug Regulation

This track will provide insights into the future of pharmacy and drug regulation in a rapidly changing healthcare landscape. Participants will discuss emerging trends and their potential impact on practice and policy.

2026 UPDATE

Consistent Academic Support

Science Net ensures that research activities continue without interruption in the current global situation. Participants can engage through digital and hybrid conference formats.